Sirio Pharma Co., Ltd. (SZSE:300791) announces a share repurchase program. Under the program, the company will repurchase its unrestricted tradable A shares for a total of CNY 40 million. The shares will be purchased at a price not exceeding CNY 40.38 per share.

The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be funded from company's own funds. The program will be valid for 12 months.